LARSON JOHN WILLIAM

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
18
Insider Sells Sum
$2.03M

Insider Activity of LARSON JOHN WILLIAM

The largest sale of all time was on 2015-01-05 and amounted to 15000 shares of Sangamo Therapeutics, Inc. for $226,550.

Biography of LARSON JOHN WILLIAM

No biography is available at this moment.

2015-01-05SaleSangamo Therapeutics, Inc.
SGMO
director
15,000
0.0216%
$15.10$226,550-32.89%
2014-12-15SaleSangamo Therapeutics, Inc.
SGMO
director
10,000
0.0165%
$16.28$162,829-24.15%
2014-12-09SaleSangamo Therapeutics, Inc.
SGMO
director
10,000
0.0129%
$12.00$120,000-16.96%
2014-11-12SaleSangamo Therapeutics, Inc.
SGMO
director
10,000
0.0148%
$12.00$120,007+0.91%
2014-10-28SaleSangamo Therapeutics, Inc.
SGMO
director
10,000
0.0144%
$12.02$120,153-1.93%
2014-09-04SaleSangamo Therapeutics, Inc.
SGMO
director
10,000
0.0149%
$12.81$128,082-2.38%
2014-08-04SaleSangamo Therapeutics, Inc.
SGMO
director
10,000
0.0143%
$12.56$125,578-1.48%
2014-04-28SaleSangamo Therapeutics, Inc.
SGMO
director
10,000
0.0148%
$13.48$134,786+0.67%
2012-12-03SaleSangamo Therapeutics, Inc.
SGMO
director
15,000
0.0294%
$5.64$84,634+74.82%
2012-11-01SaleSangamo Therapeutics, Inc.
SGMO
director
15,000
0.0286%
$5.52$82,764+69.58%
2012-10-01SaleSangamo Therapeutics, Inc.
SGMO
director
15,000
0.0286%
$6.20$93,035+43.44%
2012-09-04SaleSangamo Therapeutics, Inc.
SGMO
director
15,000
0.0273%
$5.30$79,494+52.72%
2012-08-01SaleSangamo Therapeutics, Inc.
SGMO
director
15,000
0.0302%
$5.25$78,825+58.7%
2012-07-02SaleSangamo Therapeutics, Inc.
SGMO
director
15,000
0.0272%
$5.24$78,556+18.25%
2012-06-15SaleSangamo Therapeutics, Inc.
SGMO
director
15,000
0.0281%
$5.00$75,000+22.49%
2008-07-31SaleSangamo Therapeutics, Inc.
SGMO
director
5,700
0.014%
$11.02$62,814-59.91%
2008-07-30SaleSangamo Therapeutics, Inc.
SGMO
director
3,500
0.0086%
$11.04$38,640-59.95%
2008-07-29SaleSangamo Therapeutics, Inc.
SGMO
director
19,000
0.0473%
$11.23$213,462-60.2%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.